These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 2065276)
1. Usefulness of the nude mouse model in mesothelioma based on a direct patient-xenograft comparison. Chahinian AP; Kirschner PA; Gordon RE; Szrajer L; Holland JF Cancer; 1991 Aug; 68(3):558-60. PubMed ID: 2065276 [TBL] [Abstract][Full Text] [Related]
2. Experimental and clinical activity of mitomycin C and cis-diamminedichloroplatinum in malignant mesothelioma. Chahinian AP; Norton L; Holland JF; Szrajer L; Hart RD Cancer Res; 1984 Apr; 44(4):1688-92. PubMed ID: 6423278 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of cisplatin, paclitaxel, and suramin against human malignant mesothelioma xenografts in athymic nude mice. Chahinian AP; Mandeli JP; Gluck H; Naim H; Teirstein AS; Holland JF J Surg Oncol; 1998 Feb; 67(2):104-11. PubMed ID: 9486781 [TBL] [Abstract][Full Text] [Related]
4. [A case of malignant pleural mesothelioma and its sensitivity tests for anti-cancer drugs]. Asakura S; Matsui T; Tatsumi A; Fujio A; Kitano M; Kobashi Y Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Jul; 26(7):695-9. PubMed ID: 3149385 [No Abstract] [Full Text] [Related]
5. A case report of malignant pleural mesothelioma with long-term disease control after chemotherapy. Umsawasdi T; Dhingra HM; Charnsangavej C; Luna MA Cancer; 1991 Jan; 67(1):48-54. PubMed ID: 1898706 [TBL] [Abstract][Full Text] [Related]
6. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies. Rusch VW; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M J Clin Oncol; 1992 Jun; 10(6):1001-6. PubMed ID: 1588364 [TBL] [Abstract][Full Text] [Related]
7. Augmentation of activity of cis-diamminedichloroplatinum(II) and mitomycin C by interferon in human malignant mesothelioma xenografts in nude mice. Sklarin NT; Chahinian AP; Feuer EJ; Lahman LA; Szrajer L; Holland JF Cancer Res; 1988 Jan; 48(1):64-7. PubMed ID: 2446742 [TBL] [Abstract][Full Text] [Related]
8. Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapy. Hoda MA; Mohamed A; Ghanim B; Filipits M; Hegedus B; Tamura M; Berta J; Kubista B; Dome B; Grusch M; Setinek U; Micksche M; Klepetko W; Berger W J Thorac Oncol; 2011 May; 6(5):852-63. PubMed ID: 21358348 [TBL] [Abstract][Full Text] [Related]
9. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. Rusch V; Saltz L; Venkatraman E; Ginsberg R; McCormack P; Burt M; Markman M; Kelsen D J Clin Oncol; 1994 Jun; 12(6):1156-63. PubMed ID: 8201377 [TBL] [Abstract][Full Text] [Related]
10. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial. Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752 [TBL] [Abstract][Full Text] [Related]
11. Phase-II study with the combination of cisplatin and doxorubicin in advanced malignant mesothelioma of the pleura. Henss H; Fiebig HH; Schildge J; Arnold H; Hasse J Onkologie; 1988 Jun; 11(3):118-20. PubMed ID: 3045724 [TBL] [Abstract][Full Text] [Related]
12. Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura. Kasseyet S; Astoul P; Boutin C Cancer; 1999 Apr; 85(8):1740-9. PubMed ID: 10223568 [TBL] [Abstract][Full Text] [Related]
13. The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline. Ellis P; Davies AM; Evans WK; Haynes AE; Lloyd NS; J Thorac Oncol; 2006 Jul; 1(6):591-601. PubMed ID: 17409924 [TBL] [Abstract][Full Text] [Related]
14. Clinical course of human epithelial-type malignant pleural mesothelioma replicated in an orthotopic-transplant nude mouse model. Colt HG; Astoul P; Wang X; Yi ES; Boutin C; Hoffman RM Anticancer Res; 1996; 16(2):633-9. PubMed ID: 8687108 [TBL] [Abstract][Full Text] [Related]
15. [Malignant mesothelioma of the pleura: place of surgery]. Giudicelli R; Regnard JF; Astoul P; Ruffie P Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S106-10S109. PubMed ID: 17127980 [No Abstract] [Full Text] [Related]
16. [A case of remission in diffuse pleural mesothelioma induced by anticancer chemotherapy with cisplatin and adriamycin]. Kinoshita S; Yamashita T; Yagi M; Bando H; Tsubura E; Sano T Gan To Kagaku Ryoho; 1985 Sep; 12(9):1872-6. PubMed ID: 4041164 [TBL] [Abstract][Full Text] [Related]
17. Retreatment of recurrent malignant pleural mesothelioma with cisplatin and pemetrexed. Hayashi H; Okamoto I; Ichikawa Y; Miyazaki M; Yoshioka H; Kunimasa K; Nakagawa K Int J Clin Oncol; 2010 Oct; 15(5):497-9. PubMed ID: 20224880 [TBL] [Abstract][Full Text] [Related]
18. Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts. Littlejohn JE; Cao X; Miller SD; Ozvaran MK; Jupiter D; Zhang L; Rodarte C; Smythe WR Int J Cancer; 2008 Jul; 123(1):202-8. PubMed ID: 18360826 [TBL] [Abstract][Full Text] [Related]
19. [A case of remission induced in diffuse pleural malignant mesothelioma by the treatment with cisplatin and doxorubicin]. Niki Y; Nakayama S; Soga T; Baba M; Nishimura A; Kato M; Kanamaru M Gan To Kagaku Ryoho; 1989 Nov; 16(11):3635-8. PubMed ID: 2817912 [TBL] [Abstract][Full Text] [Related]
20. Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B. Chahinian AP; Antman K; Goutsou M; Corson JM; Suzuki Y; Modeas C; Herndon JE; Aisner J; Ellison RR; Leone L J Clin Oncol; 1993 Aug; 11(8):1559-65. PubMed ID: 8336195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]